CR2 and systemic lupus erythematosus: In patients with SLE, the expression of CR1 and CR2 on B-lymphocytes is decreased by 50% and a CR2 variant with three single nucleotide polymorphisms (SNPs) was associated with a 1.54 increased risk of SLE (Wilson et al., 1986; Wu et al., 2007).